Market Intelligence chevron_right Medical Care chevron_right AAV Vector-Based Gene Therapy Drugs
Global Report 2024

Global AAV Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030

calendar_todayPublished: Jun 2024 descriptionPages: 87 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

AAV vector-based gene therapy drugs are a class of therapeutic agents used in the treatment of genetic disorders and certain diseases. These drugs utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic gene, is inserted into the AAV vector and then introduced into the patient's cells, where it is intended to correct genetic mutations or produce therapeutic proteins.

AAV vector-based gene therapy has shown promising results in clinical trials for conditions such as Leber congenital amaurosis, spinal muscular atrophy, and certain retinal diseases.

Key Features:

  • The global AAV Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030.
  • Estimated growth at a CAGR of % from 2024 to 2030.

Segmentation by Type:

  • AAV2 Vector
  • AAV5 Vector
  • Others

Segmentation by Application:

  • Hospital
  • Diagnostic and Testing Laboratories
  • Academic and Research Organizations
  • Others

Market by Region:

  • United States
  • China
  • Europe
  • Middle East & Africa

Company's Coverage:

  • uniQure
  • Spark Therapeutics
  • AveXis (Novartis)
  • PTC Therapeutics
  • BioMarin
  • Sarepta Therapeutics
  • Roche

Key Questions Addressed in this Report:

  • The report aims to provide a comprehensive analysis of the global AAV Vector-Based Gene Therapy Drugs landscape.

Frequently Asked Questions

What is the USP of the report? expand_more
AAV Vector-Based Gene Therapy Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
AAV Vector-Based Gene Therapy Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
AAV Vector-Based Gene Therapy Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.